The Prognostic Significance of the Biomarker p16 in Oropharyngeal Squamous Cell Carcinoma
Authors:
- J.S. HallJHJ.S. Hall
- N. ManiNMN. Mani
- C. DouglasCDC. Douglas
- N.J. SlevinNSN.J. Slevin
- J. HomerJHJ. Homer
- G. HallGHG. Hall
- C.M.L. WestCWC.M.L. West
- 1 November 2013
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 25 (11) , 630-638
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation studyAnnals of Oncology, 2011
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- Next‐generation treatment strategies for human papillomavirus‐related head and neck squamous cell carcinoma: where do we go?Reviews in Medical Virology, 2011
- The Mutational Landscape of Head and Neck Squamous Cell CarcinomaScience, 2011
- Trends in the incidence rates of tonsil and base of tongue cancer in England, 1985–2006The Annals of The Royal College of Surgeons of England, 2010
- Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III TrialJournal of Clinical Oncology, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)Head & Neck Oncology, 2010
- The Relationship Between Human Papillomavirus Status and Other Molecular Prognostic Markers in Head and Neck Squamous Cell CarcinomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008